Literature DB >> 6264848

In vitro and in vivo effects of dapsone on neutrophil and lymphocyte functions in normal individuals and patients with lepromatous leprosy.

R Anderson, E M Gatner, C E van Rensburg, G Grabow, F M Imkamp, S K Kok, A J van Rensburg.   

Abstract

The effects of dapsone on polymorphonuclear leukocyte functions and lymphocyte mitogen-induced transformation were assessed in vitro and in vivo in normal individuals and in newly diagnosed untreated patients with lepromatous leprosy. The effects of dapsone on the cell-free generation of superoxide by the xanthine: xanthine oxidase system and iodination of bovine serum albumin by horseradish peroxidase were also investigated. In normal individuals dapsone mediated stimulation of polymorphonuclear leukocyte migration in vitro and vivo. Dapsone had no effect on postphagocytic hexose monophosphate shunt activity in vivo. Similar effects were found in patients with lepromatous leprosy. Dapsone also decreased the inhibitory activity of serum from patients with lepromatous leprosy on normal polymorphonuclear leukocyte migration in vitro. Progressive loss of serum-mediated inhibition of migration was observed after ingestion of dapsone by the patients. Further experiments showed that stimulation of polymorphonuclear leukocyte motility was related to inhibition of lymphocyte transformation at high concentrations in vitro, but had slight stimulatory activity on phytohemagglutinin-induced transformation in controls and patients in vivo.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6264848      PMCID: PMC181465          DOI: 10.1128/AAC.19.4.495

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  26 in total

1.  Suppression of the arthus reaction in the guinea-pig by dapsone.

Authors:  D M Thompson; R Souhami
Journal:  Proc R Soc Med       Date:  1975-05

2.  The ability of chemotactic factors to induce lysosomal enzyme release. I. The characteristics of the release, the importance of surfaces and the relation of enzyme release to chemotactic responsiveness.

Authors:  E L Becker; H J Showell; P M Henson; L S Hsu
Journal:  J Immunol       Date:  1974-06       Impact factor: 5.422

3.  Quantitative and qualitative studies of the local cellular exudative response in leprosy.

Authors:  W E Bullock; M F Ho; M J Chen
Journal:  J Reticuloendothel Soc       Date:  1974-11

4.  Absorption and excretion of 35S dapsone in dermatitis herpetiformis.

Authors:  J O Alexander; E Young; T McFadyen; N G Fraser; W P Duguid; E M Meredith
Journal:  Br J Dermatol       Date:  1970-12       Impact factor: 9.302

5.  Letter: Dapsone in Crohn's disease.

Authors:  M Ward; J P McManus
Journal:  Lancet       Date:  1975-05-31       Impact factor: 79.321

6.  Classification of leprosy according to immunity. A five-group system.

Authors:  D S Ridley; W H Jopling
Journal:  Int J Lepr Other Mycobact Dis       Date:  1966 Jul-Sep

7.  H2O2 release from human granulocytes during phagocytosis. I. Documentation, quantitation, and some regulating factors.

Authors:  R K Root; J Metcalf; N Oshino; B Chance
Journal:  J Clin Invest       Date:  1975-05       Impact factor: 14.808

8.  Biological defense mechanisms. The effect of bacteria and serum on superoxide production by granulocytes.

Authors:  J T Curnutte; B M Babior
Journal:  J Clin Invest       Date:  1974-06       Impact factor: 14.808

9.  Myeloperoxidase-mediated iodination by granulocytes. Intracellular site of operation and some regulating factors.

Authors:  R K Root; T P Stossel
Journal:  J Clin Invest       Date:  1974-05       Impact factor: 14.808

10.  Inhibition of dihydropteroate synthetase from Escherichia coli by sulfones and sulfonamides.

Authors:  J L McCullough; T H Maren
Journal:  Antimicrob Agents Chemother       Date:  1973-06       Impact factor: 5.191

View more
  13 in total

1.  Dapsone as an Immunomodulator In Vivo Using the Tuberculin Skin Test as a Parameter.

Authors:  J R Snyman; W K Jacyk; D J Lizamore; K De Sommers
Journal:  Clin Drug Investig       Date:  1995-09       Impact factor: 2.859

2.  Effect of in vitro preincubation of polymorphonuclear leukocytes on formylmethionyl-leucyl-phenylalanine-induced chemiluminescence.

Authors:  C Dahlgren; O Stendahl
Journal:  Infect Immun       Date:  1982-07       Impact factor: 3.441

3.  Effects of clofazimine alone or combined with dapsone on neutrophil and lymphocyte functions in normal individuals and patients with lepromatous leprosy.

Authors:  C E van Rensburg; E M Gatner; F M Imkamp; R Anderson
Journal:  Antimicrob Agents Chemother       Date:  1982-05       Impact factor: 5.191

4.  Increased hydroxyl radical generation by normal polymorphonuclear leukocytes incubated in sera from patients with leukocytoclastic vasculitis.

Authors:  Y Miyachi; K Yanase; S Imamura; Y Niwa
Journal:  Arch Dermatol Res       Date:  1982       Impact factor: 3.017

Review 5.  Dapsone in dermatology and beyond.

Authors:  Gottfried Wozel; Christian Blasum
Journal:  Arch Dermatol Res       Date:  2013-12-06       Impact factor: 3.017

6.  Intra- and extracellular events in luminol-dependent chemiluminescence of polymorphonuclear leukocytes.

Authors:  G Briheim; O Stendahl; C Dahlgren
Journal:  Infect Immun       Date:  1984-07       Impact factor: 3.441

7.  Role of myeloperoxidase in luminol-dependent chemiluminescence of polymorphonuclear leukocytes.

Authors:  C Dahlgren; O Stendahl
Journal:  Infect Immun       Date:  1983-02       Impact factor: 3.441

8.  Inhibition of polymorphonuclear leucocyte locomotion by surface-bound antigen-antibody complexes.

Authors:  C Dahlgren; H Elwing
Journal:  Immunology       Date:  1983-06       Impact factor: 7.397

9.  The use of an amino acid as a precursor of a bioactive metabolite in combatting an infectious disease: The efficacy of a tryptophan-enriched diet in the treatment of leprosy.

Authors:  J Mauron; R Ganapati; P R Mahadevan; K Anantharaman
Journal:  Amino Acids       Date:  1992-10       Impact factor: 3.520

10.  Enhancement by clofazimine and inhibition by dapsone of production of prostaglandin E2 by human polymorphonuclear leukocytes in vitro.

Authors:  R Anderson
Journal:  Antimicrob Agents Chemother       Date:  1985-02       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.